Form 4 for OCUL OCULAR THERAPEUTIX, INC
Accepted 2025-08-14 00:00:00 ET · period of report 2025-08-12 · accession 0001104659-25-078783 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-14 | 2025-08-12 | OCUL | Waheed Nadia | Chief Medical Off | A - Grant | $0.00 | +40.4K | 247.2K | +20% | $0 |
| D | 2025-08-14 | 2025-08-12 | OCUL | Waheed Nadia | Chief Medical Off | A - Grant | $0.00 | +122.9K | 122.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-12 | A | A | 40,363 | $0.00 | 247,168 | D | — | — | (F1) On August 12, 2025, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal annual installments, beginning on February 11, 2026. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-08-12 | A | A | 122,923 | $0.00 | 122,923 | D | $12.48 · — to 2035-08-11 | 122,923 Common Stock | (F2) 7/48 of the shares underlying the option vest on September 11, 2025, and 1/48 of the shares underlying the option vest monthly thereafter through February 11, 2029. |